{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:33:13Z","timestamp":1787020393619,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81730038"],"award-info":[{"award-number":["81730038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Retroperitoneal fibrosis is a rare disease characterized by chronic nonspecific inflammation, which leads to clinical compression manifestations of retroperitoneal organs especially ureter. Approximately 70 percent of retroperitoneal fibrosis cases are idiopathic which has no clear etiology. This study reported a rare case of a 48-year-old woman presented with idiopathic retroperitoneal fibrosis and endometrial cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 48-year-old woman presented with irregular vaginal bleeding without abdominal pain, bloating or discomfort. The patient was diagnosed iRPF after splenectomy 13\u00a0years ago. Then she took prednisone for 2\u00a0years and took tamoxifen for about 11\u00a0years. She stopped taking the medication from October 2019 to May 2020 and then started taking tamoxifen again until November 2020. Two weeks after she stopped taking tamoxifen, she presented with irregular vaginal bleeding. Gynecological ultrasound revealed a thick endometrium with uneven echo enhancement and blood flow signals. Then diagnostic curettage was performed with pathological examination showed endometroid carcinoma. Later, the patient was admitted to Peking University Third Hospital for surgery. Preoperative imaging examinations, including CT, MRI, and PET\/CT, all showed pelvic enlarged lymph nodes and they were highly suspected to have lymph node metastasis. The patient underwent laparoscopic surgical staging and enlarged lymph nodes in the pelvic and aortic regions were removed. Finally, the pathology confirmed that endometrioid adenocarcinoma and fibrosis, but there was no tumor infiltration in these enlarged lymph nodes. The patient is now in good condition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case report stressed the difficulty to distinguish between lymph node metastasis and inflammatory hyperplasia by common imaging methods. Due to increased surgical difficulty among retroperitoneal patients, lymphadenectomy should be carefully evaluated to avoid additional surgical complications and over-treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-022-01968-8","type":"journal-article","created":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T19:03:54Z","timestamp":1664651034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Idiopathic retroperitoneal fibrosis with endometrial cancer: a case report and literature review"],"prefix":"10.1186","volume":"22","author":[{"given":"Manfei","family":"Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7266-1332","authenticated-orcid":false,"given":"Ying","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,1]]},"reference":[{"issue":"7","key":"1968_CR1","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1681\/ASN.2015101110","volume":"27","author":"A Vaglio","year":"2016","unstructured":"Vaglio A, Maritati F. Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol. 2016;27(7):1880\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1968_CR2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4065\/mcp.2010.0663","volume":"86","author":"TA Kermani","year":"2011","unstructured":"Kermani TA, Crowson CS, Achenbach SJ, Luthra HS. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc. 2011;86(4):297\u2013303.","journal-title":"Mayo Clin Proc"},{"issue":"9788","key":"1968_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0140-6736(11)60934-3","volume":"378","author":"A Vaglio","year":"2011","unstructured":"Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R, Ferrozzi F, Corradi D, Salvarani C, Buzio C. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet. 2011;378(9788):338\u201346.","journal-title":"Lancet"},{"issue":"5","key":"1968_CR4","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.ejim.2012.11.010","volume":"24","author":"EF van Bommel","year":"2013","unstructured":"van Bommel EF, Pelkmans LG, van Damme H, Hendriksz TR. Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis. Eur J Intern Med. 2013;24(5):444\u201350.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"1968_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000357814","volume":"93","author":"AS Brandt","year":"2014","unstructured":"Brandt AS, Kamper L, Kukuk S, Haage P, Roth S. Tamoxifen monotherapy in the treatment of retroperitoneal fibrosis. Urol Int. 2014;93(3):320\u20135.","journal-title":"Urol Int"},{"issue":"9419","key":"1968_CR6","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/S0140-6736(04)16100-X","volume":"363","author":"T Uibu","year":"2004","unstructured":"Uibu T, Oksa P, Auvinen A, Honkanen E, Metsarinne K, Saha H, Uitti J, Roto P. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet. 2004;363(9419):1422\u20136.","journal-title":"Lancet"},{"issue":"9506","key":"1968_CR7","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","volume":"367","author":"A Vaglio","year":"2006","unstructured":"Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006;367(9506):241\u201351.","journal-title":"Lancet"},{"issue":"3","key":"1968_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11926-020-00966-9","volume":"23","author":"P Fenaroli","year":"2021","unstructured":"Fenaroli P, Maritati F, Vaglio A. Into clinical practice: diagnosis and therapy of retroperitoneal fibrosis. Curr Rheumatol Rep. 2021;23(3):18.","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"1968_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","volume":"88","author":"EFH van Bommel","year":"2009","unstructured":"van Bommel EFH, Jansen I, Hendriksz TR, Aarnoudse A. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine. 2009;88(4):193\u2013201.","journal-title":"Medicine"},{"issue":"6","key":"1968_CR10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/sj.ki.5002427","volume":"72","author":"D Corradi","year":"2007","unstructured":"Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L, Ferretti S, Cobelli R, Moroni G, Dei Tos AP, et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int. 2007;72(6):742\u201353.","journal-title":"Kidney Int"},{"issue":"11","key":"1968_CR11","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","volume":"54","author":"W Lin","year":"2015","unstructured":"Lin W, Lu S, Chen H, Wu Q, Fei Y, Li M, Zhang X, Tian X, Zheng W, Leng X, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford). 2015;54(11):1982\u201390.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1968_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/rheumatology\/key324","volume":"58","author":"S Liao","year":"2019","unstructured":"Liao S, Zhang X, Zhu F, Wang Y, Zhu J, Zhang J, Huang F. Comparison of two subsets of Chinese patients with retroperitoneal fibrosis in terms of IgG4 immunohistochemical staining. Rheumatology (Oxford). 2019;58(3):455\u201362.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"1968_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1148\/radiol.14131565","volume":"272","author":"B Bakir","year":"2014","unstructured":"Bakir B, Yilmaz F, Turkay R, Ozel S, Bilgic B, Velioglu A, Saka B, Salmaslioglu A. Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study. Radiology. 2014;272(2):438\u201345.","journal-title":"Radiology"},{"issue":"10","key":"1968_CR14","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s00259-012-2144-6","volume":"39","author":"G Moroni","year":"2012","unstructured":"Moroni G, Castellani M, Balzani A, Dore R, Bonelli N, Longhi S, Martinelli I, Messa P, Gerundini P. The value of (18)F-FDG PET\/CT in the assessment of active idiopathic retroperitoneal fibrosis. Eur J Nucl Med Mol Imaging. 2012;39(10):1635\u201342.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"1968_CR15","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.eururo.2016.10.046","volume":"71","author":"A Fernando","year":"2017","unstructured":"Fernando A, Pattison J, Horsfield C, D\u2019Cruz D, Cook G, O\u2019Brien T. [(18)F]-fluorodeoxyglucose positron emission tomography in the diagnosis, treatment stratification, and monitoring of patients with retroperitoneal fibrosis: a prospective clinical study. Eur Urol. 2017;71(6):926\u201333.","journal-title":"Eur Urol"},{"issue":"2","key":"1968_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7326\/0003-4819-144-2-200601170-00007","volume":"144","author":"EF van Bommel","year":"2006","unstructured":"van Bommel EF, Hendriksz TR, Huiskes AW, Zeegers AG. Brief communication: tamoxifen therapy for nonmalignant retroperitoneal fibrosis. Ann Intern Med. 2006;144(2):101\u20136.","journal-title":"Ann Intern Med"},{"issue":"7","key":"1968_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/jcm10071380","volume":"10","author":"J Razanamahery","year":"2021","unstructured":"Razanamahery J, Bouldoires B, Humbert S, Bielefeld P, Fournier V, Bonnotte B, Blaison G, Magy-Bertrand N. Characteristics of adult patients with idiopathic retroperitoneal fibrosis and assessment of risk of relapse at diagnosis. J Clin Med. 2021;10(7):889.","journal-title":"J Clin Med"},{"issue":"23","key":"1968_CR18","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1093\/jnci\/djn397","volume":"100","author":"PP Benedetti","year":"2008","unstructured":"Benedetti PP, Basile S, Maneschi F, Alberto LA, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100(23):1707\u201316.","journal-title":"J Natl Cancer Inst"},{"issue":"9658","key":"1968_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(08)61766-3","volume":"373","author":"H Kitchener","year":"2009","unstructured":"Group A, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373(9658):125\u201336.","journal-title":"Lancet"},{"issue":"2","key":"1968_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.6004\/jnccn.2018.0006","volume":"16","author":"WJ Koh","year":"2018","unstructured":"Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, et al. Uterine neoplasms, version 1.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2018;16(2):170\u201399.","journal-title":"J Natl Compr Canc Netw"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01968-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-022-01968-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-022-01968-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T19:04:38Z","timestamp":1664651078000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-022-01968-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1968"],"URL":"https:\/\/doi.org\/10.1186\/s12905-022-01968-8","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,1]]},"assertion":[{"value":"19 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of this case report and any associated clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"399"}}